Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Hanauer

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Annals of Surgery|September 6, 2000
Side-to-side isoperistaltic strictureplasty in extensive Crohn's disease: a prospective longitudinal studyF Michelassi, R D Hurst, M Melis, et al.
Alimentary Pharmacology & Therapeutics|September 1, 2005
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurineM P Sparrow, S A Hande, S Friedman, et al.
Gastroenterology|May 1, 1993
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study GroupJ W Singleton, S B Hanauer, G L Gitnick, et al.
Alimentary Pharmacology & Therapeutics|June 5, 2013
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's diseaseW J Sandborn, D E Elliott, J Weinstock, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2011
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's diseaseM A Kamm, S B Hanauer, R Panaccione, et al.
Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2013
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's diseaseT Dassopoulos, M C Dubinsky, J L Bentsen, et al.
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
Gastroenterology|December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study GroupR N Fedorak, A Gangl, C O Elson, et al.
The New England Journal of Medicine|October 9, 1997
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study GroupS R Targan, S B Hanauer, S J van Deventer, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Annals of Surgery|September 6, 2000
Side-to-side isoperistaltic strictureplasty in extensive Crohn's disease: a prospective longitudinal studyF Michelassi, R D Hurst, M Melis, et al.
Alimentary Pharmacology & Therapeutics|September 1, 2005
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurineM P Sparrow, S A Hande, S Friedman, et al.
Gastroenterology|May 1, 1993
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study GroupJ W Singleton, S B Hanauer, G L Gitnick, et al.
Alimentary Pharmacology & Therapeutics|June 5, 2013
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's diseaseW J Sandborn, D E Elliott, J Weinstock, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2011
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's diseaseM A Kamm, S B Hanauer, R Panaccione, et al.
Inflammatory Bowel Diseases|June 1, 2001
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot studyB E Sands, W J Tremaine, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2013
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's diseaseT Dassopoulos, M C Dubinsky, J L Bentsen, et al.
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
Gastroenterology|December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study GroupR N Fedorak, A Gangl, C O Elson, et al.
The New England Journal of Medicine|October 9, 1997
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study GroupS R Targan, S B Hanauer, S J van Deventer, et al.
Pageof 15